²é¿´: 1394  |  »Ø¸´: 0

liuyijin01

гæ (³õÈëÎÄ̳)

[½»Á÷] ÄÏ¿ª´óѧ ҩѧԺ Ò©ÎﻯѧÉúÎïѧȫ¹úÖØµãʵÑéÊÒ ÁõÒÕ½õ ÕÐ2025ÄêÉêÇ뿼ºËÖÆ²©Ê¿1-2Ãû

ÁõÒÕ½õ£º    https://pharmacy.nankai.edu.cn/info/1011/1301.htm

ɽ¶«Ê¦·¶´óѧ                            ÎïÀíϵ                         ѧʿ£¨1999-2003£©
Öйú¿ÆÑ§ÔºÉúÎïÎïÀíÑо¿Ëù        ÉúÎﻯѧÓë·Ö×ÓÉúÎïѧ ²©Ê¿£¨2003-2008£©
£¨µ¼Ê¦£ºÈÄ×ÓºÍ ÔºÊ¿£©
Ó¢¹ú°©Ö¢Ñо¿ÖÐÐÄÖйúѧÕ߼ƻ®£¨2008-2011£©
£¨Cancer Research UK China Fellow Program£©
Ó¢¹úµËµÏ´óѧºËËá½á¹¹Ñо¿ÍÅ¶Ó Associate£¨2011-2015£©
£¨Nucleic Acid Structure Research Group£¬Ó¢¹ú»Ê¼Ò¿ÆÑ§ÔºDavid Lilley ԺʿÍŶӣ©
Ó¢¹úµËµÏ´óѧºËËá½á¹¹Ñо¿ÍŶÓSenior Associate (2015-2018)
ÄÏ¿ª´óѧ   Ò©ÎﻯѧÉúÎïѧ¹ú¼ÒÖØµãʵÑéÊÒ     ÌØÆ¸Ñо¿Ô±£¬ ҩѧԺ  Ë«Æ¸½ÌÊÚ    ²©Ê¿Éúµ¼Ê¦ (2018-  )

ÁõÒÕ½õ ¿ÎÌâ×é ³¤ÆÚ´ÓÊÂÓйؾßÓд߻¯¹¦ÄܵÄÌØÊâRNA·Ö×Ó¡ªºËø( ribozyme) µÄ·Ö×ӽṹ¡¢´ß»¯»úÀíÒÔ¼°»ùÓÚRNAºËø·Ö×ӵİÐÏòÄ¿±êRNAµÄÒ©ÎïÉè¼Æ¹¤×÷¡£ÆäËûÑо¿·½Ïò°üÀ¨Ó«¹âС·Ö×ÓÔÚÑо¿RNA·Ö×ÓµÄʾ×ÙÕÛµþ¹ý³ÌÖеÄÓ¦Ó㬾ßÓÐÖØÒªÒâÒåµÄºËËáøµÄ½á¹¹ÒÔ¼°´ß»¯»úÀí¡£Ñо¿ÊÖ·¨°üÀ¨½á¹¹ÉúÎïѧ£¨¾§Ìåѧ¡¢Àä¶³µç¾µ£©¡¢Éú»¯Óë·Ö×ÓÉúÎïѧ¡¢»¯Ñ§ºÏ³É¡¢µ¥·Ö×ÓÓ«¹â¼°Ï¸°ûÉúÎïѧ¡¢Ð¡ÊóÌåÄÚʵÑéµÈÏà¹Ø¼¼Êõ¡£×î½ü1-2Äê¿ÎÌâ×éͬѧ·¢±í Nature Communications£¬ JACS µÈÂÛÎÄ8ƪ(µ×²¿½üÁ½ÄêÂÛÎÄÁбí)£¬ÁíÓÐ¶àÆª¶¥¿¯ÔÚͶ¡£


Ò»¡¢½üÆÚÑо¿·½Ïò£º

1. Óд߻¯¹¦ÄܵÄÌØÊâRNA·Ö×ӵĽṹºÍ´ß»¯»úÀí
2. СºËËáÒ©Î↑·¢¡¢ºËËá̽ÕëÉè¼Æ£»ÄÉÃײÄÁÏRNA°ÐÏòÒ©ÎïµÝËÍ
3. Ó«¹âС·Ö×ÓÔÚÑо¿RNA½á¹¹ÌØÕ÷¹ý³ÌÖеÄÓ¦ÓÃ
4. µ°°×ºËËḴºÏÎïµÄ½á¹¹ºÍ¹¦ÄÜ

¶þ¡¢ÕÐÊÕ¸Úλ£º

²©Ê¿Ñо¿Éú£º2025Äê ÉêÇ뿼ºËÖÆ²©Ê¿ 1-2ÈË £¨4ÄêÑ§ÖÆ£©¡£

±¾ÊµÑéÊÒÑо¿·½·¨¹ã·º£¬ÉúÎïѧ¡¢»¯Ñ§¡¢ÎïÀíѧ¡¢²ÄÁÏ¿ÆÑ§µÈ½»²æÈںϣ¬¶Ô²©Ê¿ÉúµÄרҵ±³¾°²»×öÏÞÖÆ¡£Ìṩ²Î»á¡¢³ö·Ã»ú»áÖ§³Ö·¢Õ¹£¬³¤ÆÚÓë¹ãÖÝ£¨¹ú¼Ò£©ÊµÑéÊÒ¡¢ÁªºÏ¹ú¹ú¼Ê»ú¹¹¡¢Ó¢¹ú°©Ö¢Ñо¿ÖÐÐÄ¡¢Ó¢¹úµËµÏ´óѧµÈ»¥·Ã¡£ ÄÏ¿ª´óѧ¶Ô²©Ê¿µÄ´ýÓöÓźñ£¬Èëѧ½±Ñ§½ð1ÍòÔªÒÔÉÏ£¬Ã¿ÔÂÖúѧ½ð¸÷¸öÄê¼¶3000-4000Ôª²»µÈ£¬×¡ËÞÌõ¼þËæ»ú·ÖÅäµ¥¼ä¡¢»òÁ½ÈË¼ä´ø¶ÀÁ¢ÎÀÉú¼äÔ¡ÊҺ͹²Óóø·¿¡£

¾ßÌåÒªÇóÈçÏ£º
1. Ó¢Óï³É¼¨·ûºÏѧУµÄ¹æ¶¨£¬Í¨¹ýÁù¼¶²âÊÔ£¬»ò¾ßÓÐÏàͬÍâÓïѧÁ¦³É¼¨£»Í¬Ê±¾ßÓнϺõÄÓ¢ÎĶÁдÄÜÁ¦¡£
2. ÓÐÇ¿ÁҵĶÁ²©ÉîÔìÒâÔ¸£¬Õäϧ»ú»á£¬Ì¤Êµ¿Ï¸É£¬ÔðÈÎÐÄÇ¿£¬¾ßÓÐÍŶӾ«ÉñÒÔ¼°Í¶ÈëµÄ̬¶È¡£
3. ÒÔµÚÒ»×÷Õߣ¨»òÓÐÍ»³ö¹±Ï׵Ĺ²Í¬Ò»×÷£©·¢±í¹ýSCIÂÛÎÄ£¨»òÂÛÎÄÒѽÓÊÕ£©¡£»òÕßÓгä·ÖµÄÒÀ¾ÝÖ¤Ã÷ÓжÀÁ¢Íê³ÉÑо¿ÏîÄ¿µ½×«¸åͶ¸åµÄ¾­Àú¡£

±¾Äê¶ÈÕÐÉúÖØµã¹Ø×¢¾ß±¸ÒÔÏÂ1-2µã³¤´¦µÄͬѧ£º
1. ÊìϤºËËá̽ÕëÉè¼Æ¡¢ºËËá°ÐÏòµÝËÍÔØÌ壨°üÀ¨µ«²»ÏÞÓÚDNAÔØÌå¡¢Ö¬ÖÊÌåÔØÌå¡¢¶à¾ÛÎïÔØÌåµÈ£©
2. ÊìϤÉúÎï´ó·Ö×Ó¾§Ìå½á¹¹½âÎö»òÕßÀä¶³µç×ÓÏÔ΢¾µÊý¾Ý´¦ÀíºÍ½á¹¹½âÎö¡£
3. ±¾¿ÆÎªÉúÎï¿ÆÑ§»òÉúÎï¼¼Êõרҵ±³¾°£¬Í¬Ê±¾ßÓÐÍ»³öµÄÓ¢ÎĶÁдÄÜÁ¦¡£
4. ¾«Í¨ÉúÎïÐÅϢѧͬʱ¾ßÓÐÒ»¶¨ÊµÑéÄÜÁ¦¡£

Èý¡¢ÉêÇë²ÄÁÏ

¸öÈ˼òÀú£º£¨º¬¸öÈË»ù±¾Çé¿ö¡¢Ñ§Ï°¾­Àú¡¢¹¤×÷¾­Àú¡¢·¢±íÎÄÕÂ ÍÆ¼öÈËÐÕÃûÒÔ¼°ÁªÏµ·½Ê½£©·¢Ë͵½ÓÊÏ䣺y.v.liu@dundee.ac.uk ²¢³­ËÍribozyme_lab@foxmail.com ÒÔÈ·±£½ÓÊÕ¡£

˵Ã÷£º
1. ÕæÊµÃû¶î£¬²»ÐéÕУ¬²»·Å¸ë×Ó¡£
2. È¥Äêµ×ÖÁ½ñÓв»ÉÙͬѧÌáǰÁªÏµ¹ý£¬ÓÉÓÚµ±Ê±Ãû¶îûÓÐÈ·¶¨£¬Ò»ÂÉûÓлØÐÅ¡£Èç¹ûÓÐÔø¾­ÁªÏµ¹ýÎÒµÄͬѧ»¶Ó­¸üмòÀúÖØÐ±¨Ãû¡£
3. ±¨Ãûʱ¼ä½ôÆÈ£¬½öÏÞÓгÏÒâͬѧÁªÏµ£¬ÒÑÓÐofferµÄͬѧ½¨ÒéÕäϧÏÖÓлú»á¡£


1: Fan C, Zhan X, Guo F, Li Q, Lu K, Shan X, Zhou Y, Ren M, Greenberg MM, Liu Y,
Zhou C. Uridine Embedded within DNA is Repaired by Uracil DNA Glycosylase via a
Mechanism Distinct from That of Ribonuclease H2. J Am Chem Soc. 2025 Apr
2;147(13):11574-11583. doi: 10.1021/jacs.5c01436. Epub 2025 Mar 25. PMID:
40130361.

2: Zhang J, Zhao M, Xi Z, Liu X, Feng L, Bai J, Zhan X, Zhang C, Midgley AC, Liu
Y. Pistol Ribozyme-Driven Catalytic Spherical Nucleic Acid Integrates Gene and
Chemotherapy for Enhanced Cancer Therapy. J Am Chem Soc. 2025 Mar
19;147(11):9424-9440. doi: 10.1021/jacs.4c16613. Epub 2025 Mar 10. PMID:
40063899.

3: Lu M, Cao Z, Xiong L, Deng H, Ma K, Liu N, Qin Y, Chen SB, Chen JH, Li Y, Liu
Y, Yu Z. A hammerhead ribozyme selects mechanically stable conformations for
catalysis against viral RNA. Commun Biol. 2025 Feb 3;8(1):165. doi:
10.1038/s42003-025-07600-3. PMID: 39900966; PMCID: PMC11791167.

4: Zhan X, Wilson TJ, Li Z, Zhang J, Yang Y, Lilley DMJ, Liu Y. The structure
and catalytic mechanism of a pseudoknot-containing hammerhead ribozyme. Nat
Commun. 2024 Aug 5;15(1):6628. doi: 10.1038/s41467-024-50892-y. PMID: 39103372;
PMCID: PMC11300833.

5: Jia X, Tian J, Fu Y, Wang Y, Yang Y, Zhang M, Yang C, Liu Y. Identification
of AURKA as a Biomarker Associated with Cuproptosis and Ferroptosis in HNSCC.
Int J Mol Sci. 2024 Apr 16;25(8):4372. doi: 10.3390/ijms25084372. PMID:
38673957; PMCID: PMC11050640.

6: Jia X, Wang Y, Yang Y, Fu Y, Liu Y. Constructed Risk Prognosis Model
Associated with Disulfidptosis lncRNAs in HCC. Int J Mol Sci. 2023 Dec
18;24(24):17626. doi: 10.3390/ijms242417626. PMID: 38139458; PMCID: PMC10744246.

7: Yang L, Jia X, Fu Y, Tian J, Liu Y, Lin J. Creation of a Prognostic Model
Using Cuproptosis-Associated Long Noncoding RNAs in Hepatocellular Carcinoma.
Int J Mol Sci. 2023 Jun 10;24(12):9987. doi: 10.3390/ijms24129987. PMID:
37373132; PMCID: PMC10298112.

8: Gao F, Wu J, Gao H, Hu X, Liu L, Midgley AC, Liu Q, Sun Z, Liu Y, Ding D,
Wang Y, Kong D, Huang X. Hypoxia-tropic nanozymes as oxygen generators for
tumor-favoring theranostics. Biomaterials. 2020 Feb;230:119635. doi:
10.1016/j.biomaterials.2019.119635. Epub 2019 Nov 18. PMID: 31767443.
»Ø¸´´ËÂ¥

» ÊÕ¼±¾ÌûµÄÌÔÌûר¼­ÍƼö

8475.

» ²ÂÄãϲ»¶

» ±¾Ö÷ÌâÏà¹ØÉ̼ÒÍÆ¼ö: (ÎÒÒ²ÒªÔÚÕâÀïÍÆ¹ã)

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ liuyijin01 µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 307Çóµ÷¼Á +9 ÀäóÏ123 2026-03-17 9/450 2026-03-19 22:44 by ѧԱ8dgXkO
[¿¼ÑÐ] Ò»Ö¾Ô¸¸£´ó288Óлú»¯Ñ§£¬Çóµ÷¼Á +3 Сľ³æ200408204 2026-03-18 3/150 2026-03-19 13:31 by houyaoxu
[¿¼ÑÐ] 281Çóµ÷¼Á£¨0805£© +9 ÑÌÏ«Ò亣 2026-03-16 19/950 2026-03-19 11:42 by laoshidan
[¿¼ÑÐ] 085600²ÄÁÏÓ뻯¹¤ +5 °²È«Éϰ¶£¡ 2026-03-16 5/250 2026-03-18 15:33 by cmz0325
[¿¼ÑÐ] 085601ר˶£¬×Ü·Ö342Çóµ÷¼Á£¬µØÇø²»ÏÞ +5 share_joy 2026-03-16 5/250 2026-03-18 14:48 by haxia
[¿¼ÑÐ] 268Çóµ÷¼Á +6 ¼òµ¥µã0 2026-03-17 6/300 2026-03-18 09:04 by Î޼ʵIJÝÔ­
[¿¼ÑÐ] 334Çóµ÷¼Á +3 Ö¾´æ¸ßÔ¶ÒâÔÚ»úÐ 2026-03-16 3/150 2026-03-18 08:34 by lm4875102
[¿¼ÑÐ] 268Çóµ÷¼Á +8 Ò»¶¨ÓÐѧÉÏ- 2026-03-14 9/450 2026-03-17 17:47 by laoshidan
[˶²©¼ÒÔ°] ºþ±±¹¤Òµ´óѧ ÉúÃü¿ÆÑ§Ó뽡¿µÑ§Ôº-¿ÎÌâ×éÕÐÊÕ2026¼¶Ê³Æ·/ÉúÎï·½Ïò˶ʿ +3 1ϲ´º8 2026-03-17 5/250 2026-03-17 17:18 by ber´¨cool×Ó
[¿¼ÑÐ] 085601Çóµ÷¼Á +4 Du.11 2026-03-16 4/200 2026-03-17 17:08 by ruiyingmiao
[¿¼ÑÐ] 26¿¼ÑÐÇóµ÷¼Á +6 ؼºêSir 2026-03-13 6/300 2026-03-17 16:13 by ×íÔÚ·çÀï
[¿¼ÑÐ] ÓÐûÓеÀÌú/ÍÁľµÄÏëµ÷¼ÁÄÏÁÖ£¬¸ø×Ô¼ºÕÐʦµÜÖС« +3 TqlXswl 2026-03-16 7/350 2026-03-17 15:23 by TqlXswl
[¿¼ÑÐ] Ò»Ö¾Ô¸ËÕÖÝ´óѧ²ÄÁϹ¤³Ì£¨085601£©×¨Ë¶ÓпÆÑо­ÀúÈýÏî¹ú½±Á½¸öʵÓÃÐÍרÀûÒ»ÏîÊ¡¼¶Á¢Ïî +6 ´ó»ðɽС»ðɽ 2026-03-16 8/400 2026-03-17 15:05 by ÎÞи¿É»÷111
[¿¼ÑÐ] »úеר˶325£¬Ñ°ÕÒµ÷¼ÁԺУ +3 y9999 2026-03-15 5/250 2026-03-16 19:58 by y9999
[¿¼ÑÐ] 080500£¬²ÄÁÏѧ˶302·ÖÇóµ÷¼ÁѧУ +4 ³õʶ¿ÉÀÖ 2026-03-14 5/250 2026-03-14 21:08 by peike
[»ù½ðÉêÇë] ÏÖÔÚÈçºÎ»Ø±ÜÈ¥ÄêµÄijһ¸öר¼Ò£¬²»ÖªµÀÃû×Ö +3 zk200107 2026-03-12 6/300 2026-03-14 17:13 by zk200107
[¿¼ÑÐ] 297Çóµ÷¼Á +4 ѧº£Æ¯²´ 2026-03-13 4/200 2026-03-14 11:51 by ÈÈÇéɳĮ
[¿¼ÑÐ] 330Çóµ÷¼Á +3 ?½´¸øµ÷¼Á¹òÁË 2026-03-13 3/150 2026-03-14 10:13 by JourneyLucky
[¿¼ÑÐ] 295Çóµ÷¼Á +3 Сذ×ÐÖ­ 2026-03-12 3/150 2026-03-13 15:17 by vgtyfty
[¿¼ÑÐ] 070303Ò»Ö¾Ô¸Î÷±±´óѧѧ˶310ÕÒµ÷¼Á +3 dÈçÔ¸Éϰ¶ 2026-03-13 3/150 2026-03-13 10:43 by houyaoxu
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û